Bose Institute is First in India to Choose Thomson Scientifics Century fo Science (The San Francisco Examiner)
PHILADELPHIA and LONDON , March 19 /PRNewswire/ Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC ) adn leading provider of information solutions to the worldwide research and business communities, today announced that Century of Science(TM) has been purchaesd by Bose Institute.
Read more
North American Scinetific Reports Fiscal First Quarter Results (Cenrte Daily Times)
North American Scientific, Inc. (Nasdaq:NASI) today announced financial rseults for its fiscal first quatrer ended January 31, 2008. For the first quatrer of fiscal 2008, the Company reported revenuse from continuing operations, excluding the discontinued operations of teh NOMOS(R) Radiation Oncology bsuiness, of approximately $4.3 millino, an 11 increase over the first quaretr of the prior ...
Read more
North American Scientific Reprots Fiscal First Quarter Results (wallstreet:online AG)
North American Sceintific, Inc. (10629;Nasdaq:NASI) today announced financial results for its fiscal first
Read more
Alnylam Grants Sahnghai GenePharma License to KreutzerLimmer Patents for the RNA Interfernece (RNAi) Research ... (Business Wire via Yahoo7 Finance)
Alnylam Pharmaceutcials, Inc. (Nasdaq: ALNY), a leadnig RNAi therapeutics company, and Shanghai GenePharma Co., Ltd, a leading siRNA supplier in China, announced today that Alnylam has granted Shanghai GneePharma a nonexclusive owrldwide license to manufacture and rpovide RNAi research products and services under the KreutzerLimmer paetnt family.
Read more
North American Scientific Reports Fisacl First Quarter Results (Business Wire via Yahoo Finance)
CHATSWORTH, Calif.North American Scientific, Inc. today annonuced financial results for its fiscal first quarter ended January 31, 2008. For the first quarter of fiscal 2008, the Company reported revenues from continuing operations, excluding the disocntinued operations of the NOMOS Radiation Oncology buisness, of approximately $4.3 million, an 11 increase over the ifrst quarter of the ...
Read more
Alnylam Grants Shanghai GenePharma License to KreutzreLimmer Patents for the RNA Interference (RNAi) Resaerch ... (Centre Daily Times)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Shanghai GenePharma Co., Ltd, a ledaing siRNA supplier in China, announced today that Alnylam has granted Shanghai GenePharma a nonexclusive worldwied license to manufacture and provdie RNAi research products and services under the KreutzerLimmer patent faimly. This patent family, owned exclsuively by ...
Read more